Published in Diabetes Care on September 01, 2003
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes (2010) 1.23
Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefes Arch Clin Exp Ophthalmol (2008) 1.13
Prevalence and determinants of diabetic retinopathy in Al hasa region of saudi arabia: primary health care centre based cross-sectional survey, 2007-2009. Middle East Afr J Ophthalmol (2010) 1.12
Has the frequency of proliferative diabetic retinopathy declined in the US? Diabetes Care (2003) 0.90
Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy. J Ophthalmol (2011) 0.89
Changes in incidence of diabetes mellitus-related eye disease among US elderly persons, 1994-2005. Arch Ophthalmol (2008) 0.87
Five-year visual outcome following laser photocoagulation of diabetic macular oedema. Eye (Lond) (2011) 0.85
Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One (2013) 0.83
Hospitalized cardiovascular events in patients with diabetic macular edema. BMC Ophthalmol (2012) 0.81
Relationship between compliance with ophthalmic examinations preoperatively and visual outcome after vitrectomy for proliferative diabetic retinopathy. Jpn J Ophthalmol (2012) 0.77
The prognosis of diabetic retinopathy in patients with type 2 diabetes since 1996-1998: the Skaraborg Diabetes Register. Int Ophthalmol (2014) 0.76
Prevention of diabetic eye disease: the commonest cause of blindness in individuals younger than 65 years. Clin Ophthalmol (2010) 0.75
Participation in a National Lifestyle Change Program is associated with improved diabetes Control outcomes. J Diabetes Complications (2017) 0.75
Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care (2007) 5.41
Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 2.57
Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 2.10
Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest (2007) 1.91
Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care (2003) 1.79
Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care (2005) 1.75
Actigraphy scoring reliability in the study of osteoporotic fractures. Sleep (2005) 1.67
Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med (2011) 1.64
Nulliparity and fracture risk in older women: the study of osteoporotic fractures. J Bone Miner Res (2003) 1.62
A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults. J Manag Care Pharm (2006) 1.59
Surgical menopause and nonvertebral fracture risk among older US women. Menopause (2012) 1.52
Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids. Pain Pract (2010) 1.46
Productivity and medical costs of diabetes in a large employer population. Diabetes Care (2002) 1.30
Cost and utilization comparisons among propensity score-matched insulin lispro and regular insulin users. J Manag Care Pharm (2003) 1.23
WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis? J Bone Miner Res (2011) 1.21
Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL. Qual Life Res (2005) 1.19
Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol (2008) 1.13
Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol (2008) 1.08
Binocular visual-field loss increases the risk of future falls in older white women. J Am Geriatr Soc (2007) 1.06
Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions. Pain Pract (2010) 1.02
A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets. J Manag Care Pharm (2011) 1.01
Medical care costs among patients with established cardiovascular disease. Am J Manag Care (2010) 1.00
Increased mortality associated with the metabolic syndrome in older women with diabetes. Diabetes Care (2005) 0.98
Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures. Am J Ophthalmol (2010) 0.97
Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe. Clin Ther (2004) 0.94
Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused review. Int J Gynaecol Obstet (2004) 0.91
Pharmaceutical manufacturer prescription assistance programs: are they worth it? J Manag Care Pharm (2007) 0.90
Visual field loss and risk of fractures in older women. J Am Geriatr Soc (2009) 0.89
Associations between 25-hydroxyvitamin D and weight gain in elderly women. J Womens Health (Larchmt) (2012) 0.89
Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration. Qual Life Res (2009) 0.88
The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the study of osteoporotic fractures. Am J Ophthalmol (2012) 0.86
Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioids. Pain Pract (2011) 0.84
The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. Am J Ophthalmol (2009) 0.84
Reliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fractures. Am J Ophthalmol (2010) 0.82
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model. Ann Gen Psychiatry (2012) 0.80
The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients. J Manag Care Spec Pharm (2014) 0.80
Comparison of costs and utilization between users of insulin lispro versus users of regular insulin in a managed care setting. J Manag Care Pharm (2005) 0.79
Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials. Patient (2013) 0.78
Markedly different rates of incident insulin treatment based on universal gestational diabetes mellitus screening in a diverse HMO population. Am J Obstet Gynecol (2013) 0.78
Development of a men's Preference for Testosterone Replacement Therapy (P-TRT) instrument. Patient Prefer Adherence (2012) 0.78
Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. J Med Econ (2010) 0.78
Pharmacist intervention in safe and effective conversion of brand to generic drugs. J Manag Care Pharm (2005) 0.78
Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioids. Pain Pract (2011) 0.78
Economic implications of potential drug-drug interactions in chronic pain patients. Expert Rev Pharmacoecon Outcomes Res (2013) 0.77
Comparison of evidence-based versus non-evidence-based pharmacotherapy on the risk of cardiovascular hospitalization and all-cause mortality among patients with established cardiovascular disease. Am J Cardiol (2010) 0.76
Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%. J Med Econ (2010) 0.76
Challenges and opportunities in pharmacogenomics and therapeutics. J Manag Care Pharm (2007) 0.75
Use of economic models in formulary decisions. Expert Rev Pharmacoecon Outcomes Res (2002) 0.75
Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl. J Med Econ (2011) 0.75
Health utility and economic analysis: theoretical and practical issues. Expert Rev Pharmacoecon Outcomes Res (2009) 0.75